News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Remedent, Inc. (REMI.OB) Announces Conference Call to be Held on Monday, August 13, 2012 at 12 PM EDT to Give an Update on Recent Strategic Developments


8/13/2012 9:02:43 AM

GENT, BELGIUM--(Marketwire - August 10, 2012) - Remedent, Inc. (OTCBB: REMI), an international company specializing in research, development, and the manufacturing of oral care and cosmetic products, announced today that it will host a conference call on Monday, August 13, to update investors on the recent strategic developments.

Conference Call Information:

Remedent will host a conference call on Monday, August 13, 2012 at 12:00 p.m. Eastern Daylight Time (9:00 a.m. Pacific Daylight Time) to discuss its strategic plans for the future. A question and answer session will follow the presentation.

To participate in this call, dial the appropriate number 5-10 minutes prior to the start time.
Date: Monday, August 13, 2012
Time: 12:00 p.m. Eastern Daylight Time. (9:00 a.m. Pacific Daylight Time)
Dial in Number: 1-888-572-7025

A telephone replay of the call will be available until August 31, 2012
Toll Free Replay Number: 1-888-203-1112
Replay Password: 6066724

About Remedent

Remedent, Inc. specializes in the research, development, manufacturing and marketing of oral care and cosmetic dentistry products. The company serves professional dental industry with breakthrough technology for dental veneers. These products are supported by a line of professional veneer whitening and teeth sensitivity solutions. Headquartered in Belgium, Remedent distributes its products to more than 28 countries worldwide. For more information, go to www.remedent.com.

Forward-Looking Statements

Statements in this press release that are "forward-looking statements" are based on current expectations and assumptions that are subject to risks and uncertainties. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause Remedent's actual operating results to be materially different from any historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements that explicitly describe these risks and uncertainties, readers are urged to consider statements that contain terms such as "believes," "belief," "expects," "expect," "intends," "intend," "anticipate," "anticipates," "plans," "plan," "projects," "project," to be uncertain and forward-looking. Actual results could differ materially because of factors such as Remedent's ability to achieve the synergies and value creation contemplated by the proposed transaction. For further information regarding risks and uncertainties associated with Remedent's business, please refer to the risk factors described in Remedent's filings with the Securities and Exchange Commission, including, but not limited to, its annual report on Form 10-K and quarterly reports on Form 10-Q. We undertake no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this press release.


CONTACT:
Philippe Van Acker
+32.9.241.58.80
philippeva@remedent.be


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES